FDA Inspection 1271393 — Peter Charles Klatsky, M.D., Inc.
The FDA completed an inspection of Peter Charles Klatsky, M.D., Inc. on May 23, 2025 in San Francisco, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 23, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- San Francisco, CA (United States)